# Lucentis to Treat Pigment Epithelial Detachment

> **NCT00841581** · PHASE2 · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 32 (actual)

## Conditions studied

- Pigment Epithelial Detachment

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT00841581
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841581, "Lucentis to Treat Pigment Epithelial Detachment". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00841581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*